Targeting Semaphorin 7a Signaling in Preclinical Models of Endocrine Therapy-Resistant Breast Cancer.

Saved in:
Bibliographic Details
Title: Targeting Semaphorin 7a Signaling in Preclinical Models of Endocrine Therapy-Resistant Breast Cancer.
Authors: Steinmetz RN; Division of Medical Oncology, Department of Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.; Young Women's Breast Cancer Translational Program, University of Colorado Anschutz Medical Campus, Aurora, Colorado.; University of Colorado Cancer Center, Aurora, Colorado., Wessells V; Division of Medical Oncology, Department of Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Fairchild H; Division of Medical Oncology, Department of Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Borges VF; Division of Medical Oncology, Department of Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Lyons TR; Division of Medical Oncology, Department of Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.; Young Women's Breast Cancer Translational Program, University of Colorado Anschutz Medical Campus, Aurora, Colorado.; University of Colorado Cancer Center, Aurora, Colorado.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2026 Apr 27, pp. OF1-OF15. Date of Electronic Publication: 2026 Apr 27.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-8514
DOI:10.1158/1535-7163.MCT-25-0675